Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte total assets
Total assets on the balance sheet at the end of each period.
Incyte's total assets was $7.29B at Sep 30, 2026. For fiscal 2025 it was $6.96B, up 27.8% from the year before. Over ten years it grew 21.3% a year on average. The highest annual figure on record is $6.96B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.96B | +27.8% |
| FY2024 | Dec 31, 2024 | $5.44B | -19.7% |
| FY2023 | Dec 31, 2023 | $6.78B | +16.1% |
| FY2022 | Dec 31, 2022 | $5.84B | +18.4% |
| FY2021 | Dec 31, 2021 | $4.93B | +38.5% |
| FY2020 | Dec 31, 2020 | $3.56B | +3.9% |
| FY2019 | Dec 31, 2019 | $3.43B | +29.5% |
| FY2018 | Dec 31, 2018 | $2.65B | +14.9% |
| FY2017 | Dec 31, 2017 | $2.30B | +40.5% |
| FY2016 | Dec 31, 2016 | $1.64B | +62.6% |
| FY2015 | Dec 31, 2015 | $1.01B | +26.5% |
| FY2014 | Dec 31, 2014 | $796.48M | +26.5% |
| FY2013 | Dec 31, 2013 | $629.57M | +90.5% |
| FY2012 | Dec 31, 2012 | $330.42M | +0.4% |
| FY2011 | Dec 31, 2011 | $328.96M | -32.8% |
| FY2010 | Dec 31, 2010 | $489.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.29B | +15.1% |
| Q2 FY2026 | Jun 30, 2026 | $7.87B | +35.2% |
| Q1 FY2026 | Mar 31, 2026 | $7.34B | +27.7% |
| Q4 FY2025 | Dec 31, 2025 | $6.96B | +27.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.33B | +26.3% |
| Q2 FY2025 | Jun 30, 2025 | $5.82B | +24.9% |
| Q1 FY2025 | Mar 31, 2025 | $5.75B | -19.4% |
| Q4 FY2024 | Dec 31, 2024 | $5.44B | -19.7% |
| Q3 FY2024 | Sep 30, 2024 | $5.01B | -21.5% |
| Q2 FY2024 | Jun 30, 2024 | $4.66B | -24.9% |
| Q1 FY2024 | Mar 31, 2024 | $7.14B | +23.1% |
| Q4 FY2023 | Dec 31, 2023 | $6.78B | +16.1% |
| Q3 FY2023 | Sep 30, 2023 | $6.39B | +15.9% |
| Q2 FY2023 | Jun 30, 2023 | $6.21B | +16.7% |
| Q1 FY2023 | Mar 31, 2023 | $5.80B | +14.7% |
| Q4 FY2022 | Dec 31, 2022 | $5.84B | +18.4% |
| Q3 FY2022 | Sep 30, 2022 | $5.51B | +31.2% |
| Q2 FY2022 | Jun 30, 2022 | $5.32B | +36.2% |
| Q1 FY2022 | Mar 31, 2022 | $5.05B | +38.0% |
| Q4 FY2021 | Dec 31, 2021 | $4.93B | +38.5% |
| Q3 FY2021 | Sep 30, 2021 | $4.20B | +27.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.90B | +21.6% |
| Q1 FY2021 | Mar 31, 2021 | $3.66B | +33.0% |
| Q4 FY2020 | Dec 31, 2020 | $3.56B | +3.9% |
| Q3 FY2020 | Sep 30, 2020 | $3.31B | +2.9% |
| Q2 FY2020 | Jun 30, 2020 | $3.21B | +9.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.75B | -0.1% |
| Q4 FY2019 | Dec 31, 2019 | $3.43B | +29.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.21B | +27.6% |
| Q2 FY2019 | Jun 30, 2019 | $2.95B | +23.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.75B | +19.4% |
| Q4 FY2018 | Dec 31, 2018 | $2.65B | +14.9% |
| Q3 FY2018 | Sep 30, 2018 | $2.52B | +6.1% |
| Q2 FY2018 | Jun 30, 2018 | $2.40B | +46.2% |
| Q1 FY2018 | Mar 31, 2018 | $2.31B | +43.5% |
| Q4 FY2017 | Dec 31, 2017 | $2.30B | +40.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.37B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.64B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.61B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.64B | – |
See a number that looks wrong?